Patrick Horn, MD, discusses his recently published paper investigating the impact of left ventricular unloading on pulmonary congestion and pneumonia in patients with cardiogenic shock.
The final results of the physician-led NCSI Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used.
Christophe Vandenbriele, MD, discusses data on combining Impella® with MitraClip to optimize outcomes in cardiogenic shock with acute severe mitral regurgitation secondary to AMI.
William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock.
Ameloot et al. report significant reduction in myocardial injury with target MAP between 80/85 and 100 mmHg in post-cardiac arrest patients with shock after AMI.
Yoshiki Sawa, MD, PhD, discusses a large multicenter study in Japan demonstrating high survival rates in AMI cardiogenic shock patients receiving the Impella heart pump.
To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% on Day 6 after support with Impella RP® and Impella CP®.
Mark Anderson, MD presents his surgical perspectives on increasing survival in cardiogenic shock through escalation strategies that increase unloading.
This FAQ explains how the conclusions of Dhruva et al. conflict with Impella® best practice outcomes reported in more robust, previously published, contemporary, prospective studies.
NPS-1674
The Protected PCI community
is now on HeartRecovery.com
Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
